M&A Deal Summary

Respironics Acquires Mini-Mitter Company

On May 4, 2005, Respironics acquired medical products company Mini-Mitter Company for 11M USD

Acquisition Highlights
  • This is Respironics’ 1st transaction in the Medical Products sector.
  • This is Respironics’ 2nd largest (disclosed) transaction.
  • This is Respironics’ 2nd transaction in the United States.
  • This is Respironics’ 1st transaction in Oregon.

M&A Deal Summary
Date 2005-05-04
Target Mini-Mitter Company
Sector Medical Products
Buyer(s) Respironics
Deal Type Add-on Acquisition
Deal Value 11M USD
Advisor(s) Wells Fargo Securities (Financial)

Target

Mini-Mitter Company

Bend, Oregon, United States
Mini-Mitter develops and markets a range of physiologic monitoring products, including devices that measure sleep-wake activity, dermal and core body temperature, heart rate, and energy expenditure.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Respironics

Murrysville, Pennsylvania, United States
Category Company
Founded 1976
Sector Medical Products
Employees4,900
DESCRIPTION

Respironics is a provider in the treatment of Obstructive Sleep Apnea (OSA), a sleep disorder characterized by the repeated cessation of breathing during sleep. It is estimated that in the United States alone there are 18 – 20 million sufferers of moderate or severe OSA of which only 15 – 20% have been diagnosed. Research in recent years has shown a link between OSA, heart disease, stroke and diabetes. Additionally, the company has a leading position in noninvasive ventilation and has recently introduced new home oxygen technologies to serve the needs of respiratory impaired patients in the home. The remainder of the Company’s business is focused on the hospital channel and includes noninvasive and invasive ventilation, respiratory monitoring, neonatal products and respiratory drug delivery technologies for the treatment of respiratory diseases.

DEAL STATS #
Overall 2 of 4
Sector (Medical Products) 1 of 2
Type (Add-on Acquisition) 2 of 3
State (Oregon) 1 of 1
Country (United States) 2 of 4
Year (2005) 1 of 1
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2002-04-01 Novametrix Medical Systems

Wallingford, Connecticut, United States

Respironics Novametrix, LLC provides non-invasive cardiopulmonary monitors and sensors, developmental care products, and services to the critical care marketplace.

Buy $91M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-04-27 J.H. Emerson

Cambridge, Massachusetts, United States

J.H. Emerson Company, founded in 1928, designs and manufactures innovative and reliable medical devices. The CoughAssist® device, Emerson’s flagship product, provides secretion clearance to patients with Chronic Obstructive Pulmonary Disease as well as certain other respiratory ailments and conditions. CoughAssist® gives these patients an effortless way to remove respiratory secretions that could otherwise instigate an exacerbation of their illness.

Buy -
Mergr

Product

Company

Legal